1.Validity of Glycated Hemoglobin in Screening and Diagnosing Type 2 Diabetes Mellitus in Chinese Subjects.
Yun YU ; Xiao Jun OUYANG ; Qing Lin LOU ; Liu Bao GU ; Yong Zhen MO ; Gary T KO ; Chun Chung CHOW ; Wing Yee SO ; Ronald MA ; Alice KONG ; Nicola BROWN ; Jennifer NAN ; Juliana CHAN ; Rong Wen BIAN
The Korean Journal of Internal Medicine 2012;27(1):41-46
BACKGROUND/AIMS: The application of glycated hemoglobin (HbA1c) for the diagnosis of diabetes is currently under extensive discussion. In this study, we explored the validity of using HbA1c as a screening and diagnostic test in Chinese subjects recruited in Nanjing, China. METHODS: In total, 497 subjects (361 men and 136 women) with fasting plasma glucose (PG) > or = 5.6 mmol/L were recruited to undergo the oral glucose tolerance test (OGTT) and HbA1c test. Plasma lipid, uric acid, and blood pressure were also measured. RESULTS: Using a receiver operating characteristic curve, the optimal cutoff point of HbA1c related to diabetes diagnosed by the OGTT was 6.3%, with a sensitivity and specificity of 79.6% and 82.2%, respectively, and the area under the curve was 0.87 (95% confidence interval, 0.83 to 0.92). A HbA1c level of 6.5% had a sensitivity and specificity of 62.7% and 93.5%, respectively. When comparing the HbA1c > or = 6.5% or OGTT methods for diagnosing diabetes, the former group had significantly higher HbA1c levels and lower levels of fasting and 2-hour PG than the latter group. No significant difference was observed in the other metabolism indexes between the two groups. CONCLUSIONS: Our results suggest that HbA1c > or = 6.5% has reasonably good specificity for diagnosing diabetes in Chinese subjects, which is in concordance with the American Diabetes Association recommendations.
Aged
;
Analysis of Variance
;
*Asian Continental Ancestry Group
;
Biological Markers/blood
;
Blood Glucose/analysis
;
China/epidemiology
;
*Chromatography, High Pressure Liquid/standards
;
*Chromatography, Ion Exchange/standards
;
Diabetes Mellitus, Type 2/blood/*diagnosis/ethnology
;
Fasting/blood
;
Female
;
Glucose Tolerance Test/standards
;
Hemoglobin A, Glycosylated/*analysis
;
Humans
;
Male
;
Mass Screening/*methods/standards
;
Middle Aged
;
Predictive Value of Tests
;
ROC Curve
;
Reference Standards
;
Reproducibility of Results
;
Sensitivity and Specificity
2.Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes.
Qing Lin LOU ; Xiao Jun OUYANG ; Liu Bao GU ; Yong Zhen MO ; Ronald MA ; Jennifer NAN ; Alice KONG ; Wing Yee SO ; Gary KO ; Juliana CHAN ; Chun Chung CHOW ; Rong Wen BIAN
Diabetes & Metabolism Journal 2012;36(6):433-442
BACKGROUND: To determine the frequency of chronic kidney disease (CKD) and its associated risk factors in Chinese type 2 diabetic patients, we conducted a cross-sectional study in Nanjing, China, in the period between January 2008 and December 2009. METHODS: Patients with type 2 diabetes under the care by Jiangsu Province Official Hospital, Nanjing, China were invited for assessment. CKD was defined as the presence of albuminuria or estimated glomerular filtration rate <60 mL/min/1.73 m2. Albuminuria was defined as urinary albumin-to-creatinine ratio > or =30 mg/g. RESULTS: We recruited 1,521 urban Chinese patients with type 2 diabetes (mean age, 63.9+/-12.0 years). The frequency of CKD and albuminuria was 31.0% and 28.9%, respectively. After adjusted by age and sex, hypertension, anemia and duration of diabetes were significantly associated with CKD with odds ratio (95% confidence interval) being 1.93 (1.28 to 2.93), 1.70 (1.09 to 2.64), and 1.03 (1.00 to 1.06), respectively. CONCLUSION: In conclusion, CKD was common in the urban Nanjing Chinese with type 2 diabetes. Strategies to prevent or delay progression of kidney disease in diabetes should be carried out at the early disease course of type 2 diabetes.
Albuminuria
;
Anemia
;
Asian Continental Ancestry Group
;
China
;
Cross-Sectional Studies
;
Diabetes Mellitus, Type 2
;
Glomerular Filtration Rate
;
Humans
;
Hypertension
;
Kidney Diseases
;
Odds Ratio
;
Renal Insufficiency, Chronic
;
Risk Factors